Nidan Laboratories and Healthcare
IPO is a SME IPO coming on
NSE EMERGE with an
IPO
size of
50.00 Cr.
.
This IPO falls under the
Healthcare - Hospitals And Clinic sector, which has seen
13 IPOs
to date. Key sector metrics such as average PE ratio, IPO size, EBITDA margin, and
PAT margin are compared below with the figures from the
Nidan Laboratories and Healthcare
IPO.
IPOs So Far: 13
You can do performance analysis for Nidan Laboratories IPO with Listed IPOs in the Healthcare - Hospitals And Clinic sector and review their IPO performance based on Merchant banker, Listing price, IPO Valuation and other metrics.
This IPO report captures the post-listing performance of IPOs in the Healthcare - Hospitals And Clinic sector, featuring key metrics like offer price, listing gain, and CMP to help investors assess return potential and sector sentiment.
NAME | TYPE | OFFER PRICE | LISTING PRICE | LISTING GAIN | CMP | CMP % |
---|---|---|---|---|---|---|
Shanmuga Hospital
IPO
Financial Report >> |
SME | ₹ 54.00 | ₹ 54.00 | [●] | ₹ 41.03 | -24% |
Chandan Healthcare
IPO
Financial Report >> |
SME | ₹ 159.00 | ₹ 165.10 | 3.84% | ₹ 196.10 | 23% |
Broach Lifecare
IPO
Financial Report >> |
SME | ₹ 25.00 | ₹ 49.87 | 99.48% | ₹ 18.58 | -26% |
Nephro Care
IPO
Financial Report >> |
SME | ₹ 90.00 | ₹ 179.55 | 99.50% | ₹ 121.75 | 35% |
Maitreya Medicare
IPO
Financial Report >> |
SME | ₹ 82.00 | ₹ 154.45 | 88.35% | ₹ 277.65 | 239% |
KK Shah
IPO
Financial Report >> |
SME | ₹ 45.00 | ₹ 58.90 | 30.89% | ₹ 42.00 | -7% |
Sangani Hospitals
IPO
Financial Report >> |
SME | ₹ 40.00 | ₹ 41.85 | 4.63% | ₹ 71.50 | 79% |
Aatmaj Healthcare
IPO
Financial Report >> |
SME | ₹ 60.00 | ₹ 56.00 | -6.67% | ₹ 19.65 | -67% |
Global Longlife
IPO
Financial Report >> |
SME | ₹ 140.00 | ₹ 135.35 | -3.32% | ₹ 24.94 | -82% |
Nidan Laboratories
IPO
Financial Report >> |
SME | ₹ 125.00 | ₹ 117.75 | -5.80% | ₹ 20.80 | -83% |
Aashka Hospitals
IPO
Financial Report >> |
SME | ₹ 121.00 | ₹ 115.05 | -4.92% | ₹ 96.00 | -21% |
Kids Medical
IPO
Financial Report >> |
SME | [●] | ₹ 34.35 | 14.50% | [●] | -100% |
Tejnaksh Healthcare
IPO
Financial Report >> |
SME | [●] | ₹ 76.00 | -5.00% | ₹ 18.93 | -76% |
Nidan Laboratories and Healthcare IPO Draft red herring prospectus (DRHP) and Red Herring prospectus (RHP) are available below.
The peers of
Nidan Laboratories and Healthcare ,
include other listed companies operating in the
(Healthcare - Hospitals And Clinic) segment. These peer companies typically
offer similar services Some of the notable peers as per the DRHP of this company
are
.
See the complete list of
current IPO
Peer Comparison is the method of evaluating an entity by comparing its performance, size of business form other entities operating in same industry or sector. It involves financial analysis bycomparing key financial metrics like Profitability, Net worth, Market Capitalization and Leverage. Peer comparison is beneficial for investors to make informed investment decisions and to identify any potential risks. IPO Performance tracker
Peer comparison helps to identify companies in the same sector with a similar business. It helps to compare the financial performance and valuation against its listed peers. An investor or an analyst can decide whether the IPO price is justified when compared to its peers. An investor can make informed decision whether to apply to IPO or not on basis of peer comparison. Know the process of DRHP and Peer companies Information required to be disclosed in DRHP.
As of now 13 SME IPOs are listed in this sector indicating strong growth in this sector. Choosing the best IPO depends on factors like, financial performance, valuation, market trends and future growth plans. IPO Review and performance.
A good PE Ratio for Healthcare - Hospitals And Clinic sector depends on various factors like, performance of the company, market conditions, company valuation and IPO Size. PE Ratio varies from sector to sector and company to company. Know the average PE Multiple in each sector.
Currently 13 companies are listed under Healthcare - Hospitals And Clinic sector. Based on the latest data from the Stock Exchanges. Choose the Best Merchant Banker from the Merchant Banker List
Performance of companies depends on various factors like, profits, future plans, Market share, PE Ratio etc. By assessing these factors investor can make better investment decisions.Nidan Laboratories and Healthcare Peer comparison provides IPO analysis of companies listed in this sector, on the basis of different Key performance indicators (KPI)like, Listing Gain of peers, current market price, PE Ratio and IPO Size.
Upcoming IPO refers to companies which have filed their DRHP with the Stock exchange and are awaiting approval from NSE Emerge or BSE SME. 7 companies have filed their DRHP for SME IPO under Healthcare - Hospitals And Clinic sector. .New IPO 2025-2026 and Upcoming IPO
PE Multiple is a metrics that is widely used for IPO Valuation. Merchant bankers in coordination with the company decides the PE Multiple.The PE Multiple depends on various factors and it should be analyzed in coordination with other financial metrics. Know the PE ratio of your company with PE Calculator provided by IPOplatform
Nidan Laboratories and Healthcare operates in Healthcare - Hospitals And Clinic and Healthcare Service Provider. The Issue is listed on NSE EMERGE in Nov, 2021. Nidan Laboratories and Healthcare IPO size was 50.00 with Issue price of 125.00 .
Merchant Banker(s) of Nidan Laboratories and Healthcare IPO: First Overseas Capital Limited
Nidan Laboratories and Healthcare IPO subscription was 1.80 X. IPO subscription refers to applications received in an IPO by each quota, i.e., QIB, Retail, and NII. In some IPOs, Eligible employee quota and shareholder’s quota are also present. Learn more about IPO subscriptions here.
Nidan Laboratories and Healthcare IPO listed at a listing price of 117.75 against the offer price of 125.00.
The current market price of Nidan Laboratories and Healthcare is 20.80.
Why Us?